Strength at Home Program for Domestic Violence
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine which program more effectively reduces intimate partner violence (IPV)—the Strength at Home (SAH) program or the usual treatment (TAU). SAH is a trauma-informed program lasting 12 weeks, while TAU is a state-approved program lasting 20 weeks. The trial will assess the impact of these programs on physical and psychological IPV, PTSD symptoms, and alcohol use. Men court-mandated to attend intervention programs in Rhode Island, along with their partners, qualify for this trial. As an unphased trial, it offers participants the chance to contribute to important research that could enhance intervention programs for IPV.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research shows that the Strength at Home (SAH) program, a trauma-informed approach, effectively reduces intimate partner violence (IPV). Studies have found that participants generally respond well to this program, reporting improvements in violence-related issues and finding it helpful for dealing with trauma. Importantly, these studies have not reported significant negative effects or side effects, suggesting that the SAH program is safe for those interested in joining.
The Treatment as Usual (TAU) program is a standard, state-approved method for addressing IPV. It is widely used and considered a typical approach for IPV intervention. Although specific safety details for TAU are not provided in these sources, its approval and common use suggest it is generally safe for participants.
Overall, both programs aim to offer safe environments for addressing and reducing IPV through structured methods.12345Why are researchers excited about this trial?
The Strength at Home (SAH) program is unique because it is a trauma-informed, 12-week intervention designed specifically for intimate partner violence (IPV). Unlike the standard Treatment as Usual (TAU), which is a lengthier 20-week program, SAH aims to address the issues more efficiently by focusing on trauma, which is often a root cause of IPV. Researchers are excited about SAH because it offers a potentially quicker, more targeted approach to IPV intervention, which could lead to faster and more sustainable outcomes for participants.
What evidence suggests that this trial's programs could be effective for reducing intimate partner violence?
Research has shown that the Strength at Home (SAH) program, which participants in this trial may receive, helps reduce intimate partner violence (IPV). Participants in SAH reported experiencing less physical and emotional IPV than those who did not participate. One study found that SAH led to a noticeable drop in IPV behaviors, according to both the participants and their partners. Another study highlighted that SAH's approach, which focuses on understanding trauma and improving thinking patterns, helped enhance communication and conflict resolution skills. Overall, evidence suggests that SAH can reduce IPV and improve relationships. The trial will also compare SAH to Treatment as Usual (TAU), a 20-week state-approved IPV intervention program, to evaluate their relative effectiveness.12467
Who Is on the Research Team?
Casey T Taft, PhD
Principal Investigator
CABU School Medicine, Psychiatry
Lindsay Orchowski, PhD
Principal Investigator
Rhode Island Hospital
Are You a Good Fit for This Trial?
This trial is for men mandated by the Rhode Island court to undergo intervention for intimate partner violence (IPV) and their partners. There are no specific exclusion criteria mentioned, so it appears open to all individuals who meet the inclusion terms.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are randomized to either the Strength at Home (SAH) program for 12 weeks or the Treatment as Usual (TAU) program for 20 weeks
Follow-up
Participants are monitored for outcomes such as IPV, PTSD symptoms, and treatment satisfaction every three months post-treatment through month 12
What Are the Treatments Tested in This Trial?
Interventions
- SAH
- TAU
Find a Clinic Near You
Who Is Running the Clinical Trial?
Boston University
Lead Sponsor
Rhode Island Hospital
Collaborator
Patient-Centered Outcomes Research Institute
Collaborator